Ongoing Studies

HJKC3-0002

You are invited to take part in a study for people diagnosed with CML who have already tried stopping their TKI.

The purpose of HJKC3-0002 is to determine if adding ruxolitinib (a pill provided by the study) to your TKI for 1 year will lead to a treatment-free remission. We will monitor your CML with PCR testing.

To learn more visit clinicaltrials.gov

Questions? CureCML@mcw.edu

HJKC3-0003

You are invited to take part in a study for people diagnosed with CML who have already tried stopping their TKI.

The purpose of HJKC3-0003 is to determine if adding asciminib (a pill provided by the study) to your imatinib for 1 year will lead to a treatment-free remission. We will monitor your CML with PCR testing.

To learn more visit clinical trials.gov

Questions? CureCML@mcw.edu

HJKC3-0004

You are invited to take part in a study for people newly diagnosed with Chronic Myeloid Leukemia (CML).

The purpose of HJKC3-0004 is to determine whether using asciminib in newly diagnosed CML patients is safe and effective. We will monitor your CML with PCR testing.

To learn more visit clinicaltrials.gov

Questions? CureCML@mcw.edu